1.
Tocilizumab-Induced Limbic Encephalitis: Another Adverse Effect of Disrupted IL-6 Signalling? acmcr. 2021;5(5):704-709. Accessed September 11, 2026. https://fortunejournals.org/ojs/index.php/acmcr/article/view/22542